Glucagon-like peptide-1 receptor agonists (GLP-1RAs) such as semaglutide (Wegovy and Ozempic) and tirzepatide (Mounjaro) may ...

Opens in a new tab or window We have very little data right now to answer the question of whether we should be using a GLP-1 or GLP ... they slow gastric emptying, and we don't know what that ...

A recent commentary article published in Diabetes, Metabolic Syndrome and Obesity provides dietary recommendations for ...

American host and television producer Oprah Winfrey recently shared her initial experience of taking the weight loss drug GLP ...

Oral semaglutide administered via the RaniPill® HC (RT-116) demonstrated comparable bioavailability, pharmacokinetics and ...

Surgical patients may still have leftovers in their system even after a standard fast, potentially increasing the chance of a ...

A study on GLP1RA medications found that behavioral side effects likely do not result from direct action on GLP1R.

A brand new candidate for weight-loss treatment is on the table, with scientists uncovering for the first time how a hormone ...

While GLP-1 therapies like Ozempic gain traction, personalized peptide therapies are supporting long-term health goals ...